Christian Lildal Carranza

Dr. Christian Lildal Carranza

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 May 2018 in Journal of Cardiothoracic Surgery
Verified
Journal Article
Open access
PDF file
JPJesper Park-Hansen
Jesper Park-Hansen
SHSusanne J.V. Holme
Susanne J.V. Holme
AIAkhmadjon Irmukhamedov
Akhmadjon Irmukhamedov
CCChristian Lildal Carranza
Christian Lildal Carranza
AGAnders M. Greve
Anders M. Greve
HDHelena Dominguez
Helena Dominguez
Open heart surgery is associated with high occurrence of atrial fibrillation (AF), subsequently increasing the risk of post-operative ischemic stroke. Concomitant with open heart surgery, a cardiac ablation procedure is commonly performed in patients with known AF, often followed by left atrial appendage closure with surgery (LAACS). However, the protective effect of LAACS on the risk of cerebral ischemia following cardiac surgery remains controversial. We have studied whether LAACS in addition to open heart surgery protects against post-operative ischemic brain injury regardless of a previous AF diagnosis. One hundred eighty-seven patients scheduled for open heart surgery were enrolled in a prospective, open-label clinical trial and randomized to concomitant LAACS vs. standard care. Randomization was stratified by usage of oral anticoagulation (OAC) planned to last at least 3 months after surgery. The primary endpoint was a composite of post-operative symptomatic ischemic stroke, transient ischemic attack or imaging findings of silent cerebral ischemic (SCI) lesions. During a mean follow-up of 3.7 years, 14 (16%) primary events occurred among patients receiving standard surgery vs. 5 (5%) in the group randomized to additional LAACS (hazard ratio 0.3; 95% CI: 0.1–0.8, p = 0.02). In per protocol analysis (n = 141), 14 (18%) primary events occurred in the control group vs. 4 (6%) in the LAACS group (hazard ratio 0.3; 95% CI: 0.1–1.0, p = 0.05). In a real-world setting, LAACS in addition to elective open-heart surgery was associated with lower risk of post-operative ischemic brain injury. The protective effect was not conditional on AF/OAC status at baseline. LAACS study, clinicaltrials.gov NCT02378116 , March 4th 2015, retrospectively registered.

2 September 2024 in European Heart Journal
Verified
Journal Article
Open access
PDF file
EHEva Havers-Borgersen
Eva Havers-Borgersen
DHDorthe Hartwell
Dorthe Hartwell
CECharlotte Ekelund
Charlotte Ekelund
JBJawad H Butt
Jawad H Butt
LØLauge Østergaard
Lauge Østergaard
EFEmil L Fosbøl
Emil L Fosbøl
Background and Aims: Endometriosis, a systemic gynaecological disease affecting 10% of women in reproductive age, shares pathophysiological characteristics with cardiovascular disease. However, data on the relationship between endometriosis and cardiovascular outcomes are scarce, prompting this study to address the knowledge gap. Methods: Using Danish nationwide registries, women diagnosed with endometriosis (1977–2021) were identified and matched with controls in a 1:4 ratio based on year of birth. The primary outcome was a composite of acute myocardial infarction and ischaemic stroke. The secondary outcomes were arrhythmias, heart failure, and mortality. Results: In total, 60 508 women with endometriosis and 242 032 matched controls were included (median age 37.3 years). Women with endometriosis were more comorbid and used more medications than controls. The incidence rates of the composite outcomes were 3.2 [95% confidence interval (CI) 3.2–3.3] and 2.7 (95% CI 2.7–2.8) per 1000 person-years among women with and without endometriosis, respectively. Women with endometriosis had a significantly higher associated rate of the composite outcome compared with controls [unadjusted hazard ratio (HR) 1.18 (95% CI 1.14–1.23), adjusted HR 1.15 (95% CI 1.11–1.20)]. Likewise, women with endometriosis were also at significantly increased associated risk of arrhythmias [unadjusted HR 1.24 (95% CI 1.20–1.28) and adjusted HR 1.21 (95% CI 1.17–1.25)] and heart failure [unadjusted HR 1.16 (95% CI 1.09–1.22) and adjusted HR 1.11 (95% CI 1.05–1.18)] but at decreased risk of mortality [unadjusted HR 0.95 (95% CI 0.92–0.97) and adjusted HR 0.93 (95% CI 0.91–0.96)]. Conclusions: Women with endometriosis have a higher associated long-term risk of cardiovascular outcomes compared with controls. Despite subtle absolute risk differences, the high prevalence of endometriosis underscores the importance of these findings.

19 January 2023 in American Heart Journal
Verified
Journal Article
Closed access
EHEva Havers-Borgersen
Eva Havers-Borgersen
JBJawad H. Butt
Jawad H. Butt
LØLauge Østergaard
Lauge Østergaard
JPJeppe K. Petersen
Jeppe K. Petersen
CTChristian Torp-Pedersen
Christian Torp-Pedersen
EFEmil L. Fosbøl
Emil L. Fosbøl

1 September 2024 in European Heart Journal
Verified
Journal Article
Open access
PDF file
EHEva Havers-Borgersen
Eva Havers-Borgersen
LØLauge Østergaard
Lauge Østergaard
CHChristine Kjærsgaard Holgersson
Christine Kjærsgaard Holgersson
ASAnna Stahl
Anna Stahl
MSMichael Rahbek Schmidt
Michael Rahbek Schmidt
EFEmil L Fosbøl
Emil L Fosbøl
Patients with congenital heart disease (CHD) form a high-risk subgroup for infective endocarditis (IE), necessitating tailored prevention and treatment strategies. However, comprehensive nationwide data comparing IE characteristics and outcomes in patients with and without CHD, including children, are sparse. This study aims to address this gap in knowledge. Using Danish nationwide registries, all patients with IE from 1977 to 2021 were identified and stratified on whether they had a diagnosis of CHD, regardless of its complexity. Characteristics prior to and during admission as well as associated outcomes (i.e. in-hospital mortality, 1-year mortality, and 10-year mortality, and IE recurrence) were compared between groups. In total, 14 040 patients with IE were identified, including 895 (6.4%) with CHD. Patients with vs. without CHD were younger at the time of IE diagnosis (median age 38.8 vs. 70.7 years), less comorbid, and more frequently underwent cardiac surgery during admission (35.7% vs. 23.0%, P < .001). Notably, 76% of patients with IE < 18 years of age had CHD. The IE-related bacteraemia differed between groups: Streptococci (29.9%) were the most common in patients with CHD, and Staphylococcus aureus (29.9%) in patients without CHD. Patients with CHD had a significantly lower cumulative incidence of in-hospital mortality (5.7% vs. 17.0%, P < .001) and 1-year mortality (9.9% vs. 31.8%, P < .001) compared with those without CHD. The 10-year cumulative incidence of IE recurrence was similar between groups (13.0% and 13.9%, P = .61). Patients with CHD who develop IE exhibit distinct characteristics and improved long-term outcomes compared with patients without CHD. Notably, the majority of children and adolescents with IE have underlying CHD. The figure summarizes the study design and the main findings of the manuscript. CHD, congenital heart disease; IE, infective endocarditis.

1 November 2023 in JAMA Network Open
Verified
Journal Article
Open access
PDF file
EHEva Havers-Borgersen
Eva Havers-Borgersen
JBJawad H. Butt
Jawad H. Butt
MJMarianne Johansen
Marianne Johansen
OPOlav Bjørn Petersen
Olav Bjørn Petersen
CECharlotte Kvist Ekelund
Charlotte Kvist Ekelund
EFEmil L. Fosbøl
Emil L. Fosbøl
Preeclampsia affects 4% to 5% of pregnancies worldwide and is defined by new-onset hypertension accompanied by multiorgan involvement, including uteroplacental dysfunction.1 The exact cause and pathogenesis of preeclampsia remain unknown, but there is consensus that generalized endothelial dysfunction plays an important role.1 Thrombophilia can be either acquired or inherited and has been reported to be associated with an increased risk of preeclampsia.1-3 Likewise, thrombophilia is associated with an increased risk of venous thromboembolism (VTE), including deep vein thrombosis and pulmonary embolism—an association also observed among women during pregnancy and puerperium.4,5 Besides thrombophilia, known VTE risk factors include obesity, heart failure, cancer, inflammatory and autoimmune diseases, and venous insufficiency.2,3 As VTE remains one of the leading causes of maternal mortality,4 identifying women at increased risk is of great importance in terms of prevention.

16 November 2021 in Journal of the American Heart Association
Verified
Journal Article
Open access
PDF file
EHEva Havers‐Borgersen
Eva Havers‐Borgersen
JBJawad H. Butt
Jawad H. Butt
MSMorten Smerup
Morten Smerup
GGGunnar H. Gislason
Gunnar H. Gislason
CTChristian Torp‐Pedersen
Christian Torp‐Pedersen
EFEmil L. Fosbøl
Emil L. Fosbøl
Background: Patients with tetralogy of Fallot (ToF) are considered at high risk of infective endocarditis (IE) as a result of altered hemodynamics and multiple invasive procedures, including pulmonary valve replacement (PVR). Data on the long‐term risk of IE are sparse. Methods and Results: In this observational cohort study, all patients with ToF born from 1977 to 2018 were identified using Danish nationwide registries and followed from date of birth until occurrence of first‐time IE, emigration, death, or end of study (December 31, 2018). The comparative risk of IE among patients with ToF versus age‐ and sex‐matched controls from the background population was assessed. Because of rules on anonymity, exact numbers cannot be reported if the number of patients is <4. A total of 1164 patients with ToF were identified and matched with 4656 controls. Among patients with ToF, 851 (73.1%) underwent early surgical intracardiac repair and 276 (23.7%) underwent PVR during follow‐up. During a median follow‐up of 20.3 years, 41 (3.5%) patients with ToF (comprising 24 [8.7%] with PVR and 17 [1.9%] without PVR) and <4 (<0.8%) controls were admitted with IE. The incidence rates of IE per 10 000 person‐years were 22.4 (95% CI, 16.5–30.4) and 0.1 (95% CI, 0.01–0.7) among patients and controls, respectively. Moreover, PVR was associated with a further increased incidence of IE among patients with ToF (incidence rates per 10 000 person‐years with and without PVR were 46.7 [95% CI, 25.1–86.6] and 2.8 [95% CI 2.0–4.0], respectively). Conclusions: Patients with ToF are associated with a substantially higher incidence of IE than the background population. In particular, PVR was associated with an increased incidence of IE. With an increasing life expectancy of these patients, intensified awareness, preventive measures, and surveillance of this patient group are decisive.